RH

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of RH - RH

Retrieved on: 
Wednesday, February 15, 2023
Bank statement, NYSE, Pomerantz, Annual report, LLP, News, Cryptocurrency, Private investigator, RH

NEW YORK, Feb. 14, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of RH (“RH” or the “Company”) (NYSE: RH).

Key Points: 
  • NEW YORK, Feb. 14, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of RH (“RH” or the “Company”) (NYSE: RH).
  • Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext.
  • The investigation concerns whether RH and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

Bragar Eagel & Squire, P.C. Is Investigating DLocal, Credit Acceptance, Goldman Sachs, and RH and Encourages Investors to Contact the Firm

Retrieved on: 
Tuesday, February 14, 2023
Bank statement, Goldman Sachs, CFPB, New York State Office of Tax Enforcement, RH, Muddy Waters, Goldman, The Wall Street Journal, DLocal, DLO, NYSE, Credit Acceptance, Goldman Sachs Group, Inc. v. Arkansas Teacher Retirement System, P.C, Marcus, News, Credit, Fed, Research report, Annual report, Wall Street, New Yorker, GS, Security (finance), Cryptocurrency, Audit

Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.

Key Points: 
  • Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.
  • Additional information about each case can be found at the link provided.
  • On this news, DLocal’s share price fell $10.76, or more than 50%, to close at $10.46 per share on November 16, 2022, thereby injuring investors.
  • The CFPB stated Credit Acceptance violated New York usury laws on interest-rate limits and other consumers and investor-protection laws.

NorthStar Medical Radioisotopes Hosting Expansion Event on Wednesday, February 22, Showcasing Advanced Therapeutic Radioisotope Production Technology

Retrieved on: 
Wednesday, February 15, 2023
Science, Radiology, Biotechnology, Research, Pharmaceutical, Oncology, Health, Medical Devices, Drug Master File, University of Wisconsin–Madison, Ion Beam Applications, RH, Hospital, NorthStar, Travel, Radionuclide, Elephant, Patient, University, High energy, Cell death, Actinium-225, Radiation, Miss America, FDA, IBA, Waste management, Multimedia, RPT, Cancer, Pharmaceutical industry, Medical imaging, Borosilicate glass, United States Customs Service

Facility tours begin at 10:00 a.m.

Key Points: 
  • Facility tours begin at 10:00 a.m.
    Beloit-based NorthStar is at the forefront of radioisotope production for the United States as the only commercialized U.S. producer of the important medical radioisotope molybdenum-99 (Mo-99).
  • The electron beam accelerator production process is one of the most effective methods of producing medical radioisotopes such as Ac-225.
  • Beloit-based NorthStar Medical Radioisotopes is at the forefront of radioisotope production for the United States as the only commercialized U.S. producer of the important medical radioisotope molybdenum-99 (Mo-99).
  • NorthStar is proud to help showcase Wisconsin as a pioneer and leader in technology innovation and sustainable radioisotope production.

Blue Earth Diagnostics Highlights Upcoming Presentation of Additional Results from Investigational Phase 3 LIGHTHOUSE Study of 18F-rhPSMA-7.3 in Newly Diagnosed Prostate Cancer

Retrieved on: 
Thursday, February 9, 2023
Neurology, Radiology, Pharmaceutical, Oncology, General Health, Health, Clinical Trials, Other Health, Membrane, Safety, RH, PET, Prostate cancer, Carboxypeptidase, Multimedia, Radiopharmaceutical, ASCO, Medical imaging

Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization of innovative PET radiopharmaceuticals, today announced the presentation of additional results from its completed Phase 3 LIGHTHOUSE trial of 18F-rhPSMA-7.3 in newly diagnosed prostate cancer, at the upcoming ASCO GU 2023 Genitourinary Cancers Symposium (ASCO GU).

Key Points: 
  • Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization of innovative PET radiopharmaceuticals, today announced the presentation of additional results from its completed Phase 3 LIGHTHOUSE trial of 18F-rhPSMA-7.3 in newly diagnosed prostate cancer, at the upcoming ASCO GU 2023 Genitourinary Cancers Symposium (ASCO GU).
  • The conference will be held in San Francisco, Calif., from February 16 to 18, 2023.
  • 18F-rhPSMA-7.3 is an investigational Prostate-Specific Membrane Antigen-targeted radiohybrid (rh) PET imaging agent.
  • The now completed LIGHTHOUSE Phase 3 clinical trial ( NCT04186819 ) was a prospective, Phase 3, multi-center, single-arm, imaging study conducted in the United States and Europe to evaluate the safety and diagnostic performance of 18F-rhPSMA-7.3 Positron Emission Tomography (PET) in men with newly diagnosed prostate cancer.

RH ALERT: Bragar Eagel & Squire, P.C. is Investigating RH on Behalf of RH Stockholders and Encourages Investors to Contact the Firm

Retrieved on: 
Thursday, February 9, 2023
Class Action Lawsuit, Professional Services, Legal, Bank statement, Jeanne Eagels, NYSE, Annual report, P.C, Telephone, News, Cryptocurrency, Life insurance, RH

Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against RH (“RH” or the “Company”) (NYSE: RH) on behalf of RH stockholders.

Key Points: 
  • Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against RH (“RH” or the “Company”) (NYSE: RH) on behalf of RH stockholders.
  • Our investigation concerns whether RH has violated the federal securities laws and/or engaged in other unlawful business practices.
  • On February 6, 2023, RH announced that it expects 2022 revenue growth at the lower end of the prior range of (3.5%) to (4.5%).
  • On this news, the Company's stock price fell $25.19 per share or 7.33% percent, to close at $318.43 per share on February 6, 2023.

Kirby McInerney LLP Announces an Investigation of Shareholder Claims Against RH (RH)

Retrieved on: 
Wednesday, February 8, 2023
Class Action Lawsuit, Professional Services, Legal, Bank statement, NYSE, Annual report, Kirby, News, Private investigator, RH

The law firm of Kirby McInerney LLP is investigating potential claims against RH (“RH” or the “Company”) (NYSE: RH ).

Key Points: 
  • The law firm of Kirby McInerney LLP is investigating potential claims against RH (“RH” or the “Company”) (NYSE: RH ).
  • The investigation concerns whether RH and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices.
  • Kirby McInerney LLP is a New York-based plaintiffs’ law firm concentrating in securities, antitrust, whistleblower, and consumer litigation.
  • Additional information about the firm can be found at Kirby McInerney LLP’s website: http://www.kmllp.com .

Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of RH (RH) Investigation

Retrieved on: 
Tuesday, February 7, 2023
Legal, Professional Services, Bank statement, NYSE, Annual report, News, Cryptocurrency, RH

Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of RH (“RH” or the “Company”) (NYSE: RH).

Key Points: 
  • Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of RH (“RH” or the “Company”) (NYSE: RH).
  • Investors who purchased RH securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: www.bgandg.com/rh .
  • If you are aware of any facts relating to this investigation or purchased RH shares, you can assist this investigation by visiting the firm’s site: www.bgandg.com/rh .
  • You can also contact Peretz Bronstein or his law clerk and client relations manager, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC: 212-697-6484.

INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against RH and Encourages Investors with Losses to Contact the Firm

Retrieved on: 
Tuesday, February 7, 2023
Class Action Lawsuit, Professional Services, Legal, Bank statement, Certification, Ethics, Suite, NYSE, News, RH (company), Security (finance), Cryptocurrency, RH

The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of RH (“RH” or “the Company”) (NYSE: RH ) for violations of the securities laws.

Key Points: 
  • The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of RH (“RH” or “the Company”) (NYSE: RH ) for violations of the securities laws.
  • The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
  • We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge.
  • The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against RH and Encourages Investors with Losses to Contact the Firm

Retrieved on: 
Monday, February 6, 2023
Class Action Lawsuit, Professional Services, Legal, Bank statement, Certification, Ethics, Suite, NYSE, News, RH (company), Security (finance), Cryptocurrency, RH

The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of RH (“RH” or “the Company”) (NYSE: RH ) for violations of the securities laws.

Key Points: 
  • The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of RH (“RH” or “the Company”) (NYSE: RH ) for violations of the securities laws.
  • The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
  • We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge.
  • The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

RH CPAs Chief Visionary Officer Leon Rives Announces Three New Hires

Retrieved on: 
Friday, January 20, 2023
Business administration, M.I, Bachelor of Science, University, RH, CPAS, Growth, Rives, University of North Carolina at Charlotte, Attitude, Accounting, Master of Accountancy, Management, Science

Lexington, N.C., Jan. 20, 2023 (GLOBE NEWSWIRE) -- Accounting, tax and advisory firm RH CPAs is pleased to announce three new hires.

Key Points: 
  • Lexington, N.C., Jan. 20, 2023 (GLOBE NEWSWIRE) -- Accounting, tax and advisory firm RH CPAs is pleased to announce three new hires.
  • Robert Gaddy is an incoming Tax Associate; Ghezelle Hynes is an incoming Audit Associate; Joel Schram is an incoming Senior Tax Associate.
  • Gaddy is a native of Charlotte, N.C. and received his Master of Accountancy from the University of North Carolina at Charlotte.
  • “RH CPAs is thrilled to have the opportunity to work with such accomplished and dedicated individuals as Robert, Ghezelle and Joel,” said Leon L. Rives II, Chief Visionary Officer at RH CPAs.